Followers | 1076 |
Posts | 26372 |
Boards Moderated | 12 |
Alias Born | 01/11/2016 |
Monday, April 20, 2020 1:47:24 PM
Recent RCUS News
- Arcus Biosciences to Participate in the Bank of America Healthcare Conference 2024 • Business Wire • 05/02/2024 08:05:00 PM
- Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting • Business Wire • 04/24/2024 08:00:00 PM
- Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update • Business Wire • 04/23/2024 08:05:00 PM
- Arcus Biosciences Announces New Employment Inducement Grants • Business Wire • 04/09/2024 08:35:00 PM
- Arcus Biosciences Announces New Employment Inducement Grants • Business Wire • 03/26/2024 08:35:00 PM
- Arcus Biosciences Announces New Employment Inducement Grants • Business Wire • 03/11/2024 08:35:00 PM
- Arcus Biosciences to Participate in Two Upcoming Investor Conferences • Business Wire • 02/28/2024 09:05:00 PM
- Arcus Biosciences Announces New Employment Inducement Grants • Business Wire • 02/27/2024 09:35:00 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 02/21/2024 09:53:37 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/21/2024 09:32:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:08:24 PM
- Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update • Business Wire • 02/21/2024 09:05:00 PM
- Arcus Biosciences Announces New Employment Inducement Grants • Business Wire • 02/09/2024 09:35:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 11:58:17 PM
- Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2023 Financial Results and Pipeline Updates • Business Wire • 02/07/2024 10:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 01:17:44 PM
- Arcus Biosciences Stock Jumps 20% on $320M Gilead Investment, Super Micro Surpasses Forecasts, and More News • IH Market News • 01/30/2024 11:25:14 AM
- Gilead and Arcus Announce Amended Collaboration and Equity Investment • Business Wire • 01/29/2024 10:00:00 PM
- Gilead and Arcus Announce Amended Collaboration and Equity Investment • Business Wire • 01/29/2024 10:00:00 PM
- Arcus Biosciences Announces New Employment Inducement Grants • Business Wire • 01/26/2024 09:35:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 12:39:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 12:39:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 12:38:55 AM
- Data from a Phase 1b Study of Quemliclustat-Based Regimens Showed Promising Overall Survival in Treatment-Naïve Metastatic Pancreatic Cancer • Business Wire • 01/16/2024 10:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 09:06:35 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM